Infliximab 120 mg

Open

In brief

Central Military Hospital - Military University Hospital Prague is procuring ongoing supplies of the medicinal product Infliximab 120 mg in Prague, Czechia. The estimated value is 17459966 CZK. The submission deadline is 26 November 2026. The notice, tender documents, and submission instructions are available on the nen.nipez.cz portal.

Updated October 27, 2026

Deadline

29 days left

November 26, 2026

Contract Details

Key facts

Buyer: Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha
Estimated value: €17,459,966
Deadline: November 26, 202629 days left
CPV Code: 33652300-8 — Immunosuppressive agents
Procedure: Open procedure
Source: Procurement Portal

Budget

€17,459,966

Duration

Not specified

Location

CZ010

Type

Other

Original Tender Description

Předmětem této veřejné zakázky jsou průběžné dodávky léčivého přípravku s léčivou látkou INFLIXIMAB pro potřeby Ústřední vojenské nemocnice – Vojenské fakultní nemocnice Praha v souladu se zadávacími podmínkami

Risk Analysis

Risk analysis is not yet available for this country's tenders. Currently supported: Estonia, Latvia, Lithuania, Poland, France, UK, Denmark, Netherlands, Norway, and Finland.

Win Strategy

Get an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Requirements & Qualifications

AI extracts and organizes all requirements from tender documents — mandatory qualifications, technical specifications, financial conditions, and submission rules — clearly categorized so you know exactly what's needed to bid.

Basic Requirements

Company registration in EU required
Proven track record in similar projects
Financial stability documentation